Nuvation Bio Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
3.640
-0.330 (-8.31%)
At close: Mar 28, 2024, 4:00 PM
3.690
+0.050 (1.37%)
After-hours: Mar 28, 2024, 7:59 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $797.33 million as of March 28, 2024. Its market cap has increased by 109.44% in one year.
Market Cap
797.33M
Enterprise Value
190.12M
1-Year Change
109.44%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since July 1, 2020, Nuvation Bio's market cap has increased from $181.60M to $797.33M, an increase of 339.06%. That is a compound annual growth rate of 48.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 869.60M | 37.83% |
Mar 26, 2024 | 630.90M | 28.00% |
Mar 25, 2024 | 492.90M | -2.59% |
Mar 22, 2024 | 506.00M | 3.12% |
Mar 21, 2024 | 490.70M | 16.67% |
Mar 20, 2024 | 420.60M | -3.99% |
Mar 19, 2024 | 438.10M | -11.49% |
Mar 18, 2024 | 495.00M | -0.88% |
Mar 15, 2024 | 499.40M | 4.11% |
Mar 14, 2024 | 479.70M | -9.13% |
Mar 13, 2024 | 527.90M | 3.43% |
Mar 12, 2024 | 510.40M | -2.50% |
Mar 11, 2024 | 523.50M | -2.06% |
Mar 8, 2024 | 534.50M | -2.00% |
Mar 7, 2024 | 545.40M | 4.18% |
Mar 6, 2024 | 523.50M | 9.63% |
Mar 5, 2024 | 477.50M | 2.82% |
Mar 4, 2024 | 464.40M | -4.93% |
Mar 1, 2024 | 488.50M | 19.26% |
Feb 29, 2024 | 409.60M | -5.03% |
Feb 28, 2024 | 431.30M | -1.01% |
Feb 27, 2024 | 435.70M | 0.51% |
Feb 26, 2024 | 433.50M | 11.24% |
Feb 23, 2024 | 389.70M | 0.57% |
Feb 22, 2024 | 387.50M | -0.56% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Avanos Medical | 905.14M |
Healthcare Services Group | 894.03M |
Arcturus Therapeutics Holdings | 884.43M |
CARGO Therapeutics | 882.13M |
Canopy Growth | 870.14M |
Evolus | 860.97M |
Cassava Sciences | 851.97M |
Pliant Therapeutics | 851.78M |